Trial site
Guangdong Provincial Peoples Hospital
- 12running trials
- 12closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Chronic kidney disease2 trials
- Chronic lymphocytic leukaemia2 trials
- Gastric and oesophageal cancer2 trials
- Myeloproliferative neoplasms2 trials
- Obesity2 trials
- Acute myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Heart failure1 trial
- High blood pressure1 trial
- IgA nephropathy1 trial
- and 6 more
- Phase
- Phase 312 trials
- Phase 24 trials
- Phase 12 trials
- Phase 1/22 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed11 trials
- Active, not recruiting7 trials
- Recruiting5 trials
- Terminated1 trial
- Lead sponsor
- BeiGene9 trials
- Amgen5 trials
- BeOne Medicines4 trials
- Guangdong Provincial People's Hospital2 trials
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
- and 3 more
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
National Registry and Cohort Study of Pulmonary Vascular Disease
Recruiting
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Lung cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Obesity1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
Completed
Completed
Completed
Completed
A Clinical Trial of TQ05105 Tablets in the Treatment of Moderate and High Risk Myelofibrosis
Terminated
Completed
Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026